Dementia is becoming a major health problem as the population of the Northe
rn Hemisphere ages. Early differential diagnosis between normal cognitive d
ecline and dementia is particularly difficult. If psychometric evaluation c
an contribute to the diagnosis, quantitative cerebral functional imaging wo
uld play an important role. We therefore proposed, first, to constitute a n
ormative dataset that could later be used to identify subjects at risk for
neurodegenerative processes and, second, to describe the risk of abnormal g
lobal cerebral blood flow (gCBF) by defining categories based on the standa
rdized cutoff scores of a young, healthy population (T-score). Methods: Of
a total of 203 healthy volunteers, 187 were included in the protocol, which
included evaluation of medical history, neurologic and neuropsychologic st
atus, and body composition; analysis of blood; and measurement of gCBF by m
eans of Xe-133 SPECT. Results: With ANOVA analysis using age and sex as bet
ween-subject factors and gCBF as a within-subject factor, a significantly h
igher gCBF was found in women than in men. In addition, a linear reduction
as a function of age was observed for both sexes (-0.3%/y). T-score was det
ermined for the 18- to 28-y-old age group, for whom gCBF was found to be 46
.7 +/- 5.1 mL/min/100 g tissue in men and 49.0 +/- 5.0 mL/min/100 g tissue
in women. The age-dependent decrease could thus be expressed in T-scores an
d, in the 29- to 38-y-old, 39- to 48-y-old, and >48-y-old age groups, avera
ged -0.63, -1.29, and -1.92, respectively, in men and -0.63, -0.83, and -2.
40, respectively, in women. Cognitive performance, body composition, and bl
ood analysis revealed the expected significant effects from sex and age. Co
nclusion: The large-scale reference database of gCBF measurements constitut
ed from a healthy, well-controlled population enabled age and sex stratific
ation, which showed significant differences between the sexes and a signifi
cant decline as a function of age. T-scores were determined and warrant fur
ther studies on the prospective identification of early dementia by Xe-133
SPECT in elderly individuals.